Julie Bernhardt

Last updated

Julie Bernhardt AM FAHMS is an Australian physiotherapist and clinician scientist, a Principal Research Fellow and an NHMRC Senior Research Fellow and Clinical Head of the Stroke Division at the Florey Institute of Neuroscience and Mental Health, University of Melbourne. Bernhardt is Principal Investigator of the 'A Very Early Rehabilitation Trial' (AVERT) and a leader in the field of stroke recovery.

Contents

Bernhardt is the director of the NHMRC Centre of Research Excellence (CRE) in Stroke Rehabilitation and Brain Repair, a collaboration between the Florey Institute of Neuroscience and Mental Health, the Hunter Medical Research Institute and other institutions. [1] She founded and chaired the international Stroke Recovery and Rehabilitation Roundtable (SRRR), a partnership involving leading stroke experts which aims to advance stroke rehabilitation research. [2] She led the second SRRR in 2018, on developing international clinical trials to improve stroke treatment. [3]

Education

In 1985, Bernhardt completed a Bachelor of Applied Science in Physiotherapy at the Lincoln Institute of Health Sciences, Melbourne, Victoria, Australia. [4] From 1990 to 1995 she undertook a Masters of Applied Science at La Trobe University where she also received her PhD in 1999. [4] The focus of her PhD research was on the hemiplegic upper limb, and she developed new methods of testing the accuracy of observational kinematic assessment of upper limb dysfunction. [5] [6] [7]

Career

Bernhardt began work as a Physiotherapy Research Coordinator at Melbourne Health in 1989, [8] then after completing her PhD, she was a senior physiotherapist at the Austin and Royal Melbourne Hospitals from 1999–2008. [9] She became a Professor in Neuroscience at La Trobe University, Melbourne in 2006. Bernhardt is Head of Stroke Division at the Florey Institute of Neuroscience and Mental Health at the University of Melbourne. [4]

In 2004, Bernhardt joined the Florey Institute to become Principal Investigator of the AVERT Early Intervention Research Group. AVERT was the largest acute stroke rehabilitation trial in the world. Over 2000 stroke patients were recruited from 56 acute stroke units in Australia, New Zealand, the United Kingdom, Malaysia, and Singapore from 2006–2014. [10] Within the AVERT group, Bernhardt led a team of over 1000 clinicians and researchers. The trial aimed to identify if receiving very early mobilisation (VEM) within 24 hours of stroke is beneficial for stroke recovery, and if so, how much and what frequency is best. [11] The studies in AVERT focused on understanding how these early exercise-based interventions after stroke may alter bone, muscle and brain. [9] The results of AVERT were presented at the European Stroke Organisation Conference in Glasgow, April, 2015. While AVERT was completed in 2016, Bernhardt continues to lead the extension of the trial, AVERT-DOSE (Determining Optimal early rehabilitation after Stroke). [12] This trial tests eight different mobility training regimens to see what dose of mobility training is best early after stroke. AVERT-DOSE is recruiting over 2500 patients in six countries: Australia, New Zealand, the United Kingdom, Malaysia, Singapore, and India. [12]

From 2006-2014, Bernhardt was a non-executive director for the National Stroke Foundation. She has been on the Steering Committee of the Australian Stroke Research Network since 2011 and from 2013–16, she was Co-Chair for Australasian Stroke Trials Network. [13] Since 2015, Bernhardt has also been the Director of the NHMRC Centre of Research Excellence in Stroke Rehabilitation, [1] which aims to accelerate discovery and translation in the field of stroke rehabilitation [14] She was Chair of the research committee for the World Federation of Neurorehabilitation from 2016-2020. Bernhardt has been on the board of the World Stroke Organisation since July 2014 and Chair of the research committee of WSO since April 2017. [13] She also founded and leads the Stroke Recovery and Rehabilitation Roundtable, which brings together researchers, clinicians, funders and consumers to identify key stroke research priority areas. [2]

Bernhardt has published 345 scholarly works, most in the field of stroke rehabilitation. [15]

Personal

Bernhardt lives in Melbourne, Australia with her husband and teenage son. [16]

Awards and honours

Advocacy

In 2013, Bernhardt founded the Women in Science Parkville Precinct (WiSPP) Collective Impact initiative to address the gender inequity that she had witnessed in medical research. [25] This initiative aims to improve the systems that limit the advancement of women and diversity of leadership across five of Melbourne's medical research institutes. Bernhardt was invited to talk at the 2016 World Economic Forum in Tianjin, China about gender equity [26] and is also an author on a paper about gender equity in Stroke Society of Australasia. [27]

Related Research Articles

<span class="mw-page-title-main">Howard Florey</span> 20th-century Australian pathologist

Howard Walter Florey, Baron Florey was an Australian pharmacologist and pathologist who shared the Nobel Prize in Physiology or Medicine in 1945 with Sir Ernst Chain and Sir Alexander Fleming for his role in the development of penicillin.

<span class="mw-page-title-main">Florey Institute of Neuroscience and Mental Health</span>

The Florey Institute of Neuroscience and Mental Health, more commonly known as the Florey Institute, is an Australian medical research institute that undertakes clinical and applied research into treatments for brain and mind disorders and the cardiovascular system. The institute's areas of interest include Parkinson's disease, stroke, motor neurone disease, traumatic brain and spinal cord injury, addiction, epilepsy, multiple sclerosis, brain development in premature babies, Autism, Huntington's disease, depression, schizophrenia, brain function in health and disease, heart failure, and dementia.

Faculty of Medicine, Dentistry and Health Sciences of the University of Melbourne has the largest number of post-graduate enrolments in the University of Melbourne and also hosts the most school departments and centres of all University of Melbourne Faculties, consisting of 52 faculty sub-organisations. In 2021, Melbourne Medical School was ranked 25th in the world and second in Australia in the 2021 QS Subject Rankings.

The National Health and Medical Research Council (NHMRC) is the main statutory authority of the Australian Government responsible for medical research. It was the eighth largest research funding body in the world in 2016, and NHMRC-funded research is globally recognised for its high quality. Around 45% of all Australian medical research from 2008–12 was funded by the federal government, through the NHMRC.

Louise McCullough M.D., Ph.D is the Prof. Roy M. & Phyllis Gough Huffington Distinguished Chair of Neurology and a practicing vascular neurologist and professor who is actively engaged in stroke research at the University of Texas Health Science Center in Houston, Texas. She provides neurological care at Memorial Hermann Hospital, which has a state-of-the-art stroke center and is co-director of the Mischer Neuroscience Institute.

The Mental Health Research Institute (MHRI) is a former Australian medical research institute that was focused upon improving the diagnosis, treatment and prevention of major mental disorders. The MHRI was active between 1956 and 2012, when it was merged with the Florey Neuroscience Institutes to form the Florey Institute of Neuroscience and Mental Health. Based in Melbourne, Victoria, the research efforts of the MHRI were focused on understanding schizophrenia, bipolar and major mood disorders, and Alzheimer's disease.

<span class="mw-page-title-main">Neuroscience Research Australia</span>

Neuroscience Research Australia is an independent medical research institute based in Sydney, Australia. Previously called the Prince of Wales Medical Research Institute, the institute relaunched as Neuroscience Research Australia on 1 June 2010. NeuRA is accredited by the National Health and Medical Research Council.

<span class="mw-page-title-main">Josephine Forbes</span> Australian scientist

Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.

Elizabeth Scarr is an Australian scientist. Her research investigates the chemical changes in the brain associated schizophrenia and bipolar disorder.

Jennie Louise Ponsford is an Australian neuroscience researcher at Monash University, Victoria who has a special interest in Traumatic Brain Injury (TBI). Jennie is a clinical neuropsychologist, whose work is focused on developing a deeper understanding of the negative consequences of TBI, particularly those related to fatigue, sleep disturbance, attentional problems, mood and behavioural disturbances, and the development of rehabilitation interventions to improve long term recovery and quality of life in individuals with TBI.

<span class="mw-page-title-main">Leeanne Carey</span> Australian occupational therapist and neuroscientist

Professor Leeanne Carey is a world leading Australian neuroscientist in occupational therapy and stroke rehabilitation and recovery research. She is the founding leader of the Neurorehabilitation and Recovery research group in the Stroke division at the Florey Institute of Neuroscience and Mental Health in Melbourne, Australia, and currently holds a Future Fellowship awarded by the Australian Research Council (ARC).

Mary Pauline Galea is an Australian physiotherapist and neuroscientist at University of Melbourne. She resides in Melbourne, Australia. Galea is a professorial fellow at the University of Melbourne's Department of Medicine at the Royal Melbourne Hospital and a Senior Principal Fellow in the Florey Institute of Neurosciences and Mental Health. She was foundation professor of clinical physiotherapy and director of the Rehabilitation Sciences Research Centre at the University of Melbourne and Austin Health. She is internationally recognised for her work in spinal cord injury and rehabilitative interventions.

Jerome Sarris is Co-Director of Psychae Institute, Professor of Integrative Mental Health at Western Sydney University, Australia, and a visiting scientist at the Florey Institute of Neuroscience and Mental Health at the University of Melbourne, Australia.

Matire Louise Ngarongoa Harwood is a New Zealand clinical researcher and trainee general practitioner.She is an associate professor at the University of Auckland. Harwood was the 2017 New Zealand L'Oréal UNESCO For Women in Science Fellow. Her expertise is in Māori health, focussed on reducing health inequity by improving indigenous health and well-being.

Professor Anne Kelso is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).

<span class="mw-page-title-main">Rachelle Buchbinder</span> Australian rheumatologist and medical researcher

Rachelle Buchbinder is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.

Janice Jennifer Eng is a professor in the University of British Columbia's Department of Physical Therapy and Canada Research Chair in Neurological Rehabilitation.

<span class="mw-page-title-main">Emily Banks</span> Epidemiologist and public health researcher

Emily Banks is an epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting Professor at the University of Oxford.

Jennifer Helen Martin is an Australian clinical pharmacologist, physician and academic. She is chair of Clinical Pharmacology in the University of Newcastle School of Medicine and Public Health, Director of the NHMRC funded Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), and an elected a Fellow of the Australian Academy of Health and Medical Sciences. Martin translates research into practice and policy. Her research involves the investigation of therapeutic drugs, from drug design and development, to clinical trials and studies to investigate how new drugs perform in the general population.

Julie Bines, is a clinician and researcher working in Melbourne, Australia. Alongside being a professor and deputy head of the Department of Paediatrics at the University of Melbourne, she is also a paediatric gastroenterologist at the Royal Children's Hospital Melbourne and is the leader of the Enteric Diseases group at the Murdoch Children's Research Institute. Bines is the joint head of the WHO Collaborative Centre for Child Health and founding member of Women in Global Health Australia.

References

  1. 1 2 "Our People". Stroke Recovery Research CRE. Retrieved 12 September 2018.
  2. 1 2 Bernhardt, Julie; Hayward, Kathryn; Kwakkel, Gert; Ward, Nick; Wolf, Steven; Borschmann, Karen; Krakauer, John; Boyd, Lara; Carmichael, S. Thomas; Corbett, Dale; Cramer, Steven (21 September 2017). "Agreed Definitions and a Shared Vision for New Standards in Stroke Recovery Research: The Stroke Recovery and Rehabilitation Roundtable Taskforce". Neurorehabilitation and Neural Repair. 31 (9): 793–799. doi: 10.1177/1545968317732668 . PMID   28934920.
  3. ↑ Borschmann, Karen. "Stroke Recovery and Rehabilitation Roundtable – June 2018 update". Stroke Recovery Research CRE. Retrieved 13 September 2018.
  4. 1 2 3 "ORCID". orcid.org. Retrieved 9 April 2022.
  5. ↑ Bernhardt, J. A. (1998). Observational kinematic assessment of upper limb movement. Doctoral dissertation, La Trobe University.
  6. ↑ Bernhardt, Julie; Bate, Patricia J; Matyas, Thomas A (1 March 1998). "Accuracy of Observational Kinematic Assessment of Upper-Limb Movements". Physical Therapy. 78 (3): 259–270. doi:10.1093/ptj/78.3.259. ISSN   0031-9023. PMID   9520971.
  7. ↑ Bernhardt, Julie; Ellis, Paul; Denisenko, Sonia; Hill, Keith (1998). "Changes in balance and locomotion measures during rehabilitation following stroke". Physiotherapy Research International. 3 (2): 109–122. doi:10.1002/pri.130. ISSN   1358-2267. PMID   9648176.
  8. ↑ "Neurosciences Centre of Research Excellence: Staff". Neurosciences Centre of Research Excellence. Neurosciences Centre of Research Excellence. Retrieved 6 November 2014.
  9. 1 2 "Julie Bernhardt". LinkedIn. LinkedIn. Archived from the original on 6 November 2014. Retrieved 6 November 2014.
  10. ↑ "A Very Early Rehabilitation Trial (AVERT) - Database Projects". Florey. Retrieved 19 September 2018.
  11. ↑ Bernhardt, Julie; Churilov, Leonid; Ellery, Fiona; Collier, Janice; Chamberlain, Jan; Langhorne, Peter; Lindley, Richard; Moodie, Marj; Dewey, Helen; Thrift, Amanda; Donnan, Geoff (7 June 2016). "Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)". Neurology. 23 (86): 2138–2145. doi:10.1212/WNL.0000000000002459. PMC   4898313 . PMID   26888985.
  12. 1 2 "AVERT-DOSE (Determining Optimal early rehabilitation after StrokE): A multi-arm covariate-adjusted, response-adaptive randomised controlled trial". Research Data Australia. Retrieved 19 September 2018.
  13. 1 2 3 4 "Australia Day 2019 Honours List". Governor-General of the Commonwealth of Australia. Archived from the original on 27 May 2019. Retrieved 30 January 2019.
  14. ↑ "Our Research". Stroke Recovery Research CRE. Retrieved 12 September 2018.
  15. ↑ "Prof Julie Bernhardt". findanexpert.unimelb.edu.au. Retrieved 10 April 2022.
  16. ↑ "Life as a scientist can mean directly helping those who suffer". Women's Agenda. Retrieved 6 November 2014.
  17. ↑ "Bernhardt, Julie's Fellowship Profile". Winston Churchill Memorial Trust. Retrieved 13 September 2018.
  18. ↑ "100 Women of Influence 2016". afr.com. Retrieved 13 September 2018.
  19. ↑ "Awards supported by the Austin Medical Research Foundation, AMRF, Melbourne Australia". Austin Medical Research Foundation. Retrieved 13 September 2018.
  20. ↑ "American Stroke Association honors nine outstanding contributors to stroke, research". American Heart Association. Retrieved 13 September 2018.
  21. ↑ "Our 2016 CEW Scholars - Chief Executive Women". Chief Executive Women. Retrieved 7 April 2022.
  22. ↑ "UKSF Conference 2015 - At A Glance Programme" (PDF). Stroke Association. Retrieved 13 September 2018.
  23. ↑ "Winners announced: NAB Womens Agenda Leadership Awards 2015". Angela Priestley.
  24. ↑ "Academy elects 28 new Fellows". AAHMS - Australian Academy of Health and Medical Sciences. 14 October 2020. Retrieved 7 December 2020.
  25. ↑ "Team 1". WiSPP. Retrieved 10 April 2022.
  26. ↑ "Australia Day Honour for Professor Julie Bernhardt" . Retrieved 10 April 2022.
  27. ↑ Carcel, Cheryl; Woodward, Mark; Anderson, Craig S.; Delcourt, Candice; Bernhardt, Julie; Gall, Seana (2022). "Gender Equity in Leadership and Conferences of the Stroke Society of Australasia". Cerebrovascular Diseases. 51 (1): 125–130. doi:10.1159/000517453. ISSN   1015-9770. PMID   34265764. S2CID   235959393.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.